Thrombopoietin stimulates migration and activates multiple signaling pathways in hepatoblastoma cells

American Journal of Physiology - Gastrointestinal and Liver Physiology

Volumn 290, Issue 1, 2006, Pages

  Romanelli, Roberto G ^a   Petrai, Ilaria ^a   Robino, Gaia ^b   Efsen, Eva ^a   Novo, Erica ^b   Bonacchi, Andrea ^a   Pagliai, Gabriella ^c   Grossi, Alberto ^c   Parola, Maurizio ^b   Navari, Nadia ^a   Delogu, Wanda ^a   Vizzutti, Francesco ^a   Rombouts, Krista ^a   Gentilini, Paolo ^a   Laffi, Giacomo ^a   Marra, Fabio ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

^b UNIVERSITY OF TURIN   (Italy)

^c CAREGGI UNIVERSITY HOSPITAL   (Italy)

Author keywords

Apoptosis; Invasion; Mitogen activated protein kinases; Mpl; Nuclear factor B; Phosphatidylinositol 3 kinase

Indexed keywords

ANTIBODY; ENZYME INHIBITOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MATRIGEL; MITOGEN ACTIVATED PROTEIN KINASE; ONCOPROTEIN; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; PROTO ONCOGENE PROTEIN C MPL; STRESS ACTIVATED PROTEIN KINASE; THROMBOPOIETIN; THROMBOPOIETIN RECEPTOR; UNCLASSIFIED DRUG; CYTOKINE RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE KINASE; MPL PROTEIN, HUMAN;

ANTIGEN ANTIBODY COMPLEX; APOPTOSIS; ARTICLE; CANCER CELL; CELL CULTURE; CELL LINE; CELL MIGRATION; CELL TYPE; CHEMOKINESIS; CHEMOTAXIS; CONTROLLED STUDY; DOSE RESPONSE; ENZYMATIC ASSAY; ENZYME ACTIVATION; GENETIC TRANSCRIPTION; HEPATOBLASTOMA; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; LIVER CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FAMILY; PROTEIN PHOSPHORYLATION; PROTO ONCOGENE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; WESTERN BLOTTING; CELL MOTION; DRUG EFFECT; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; PATHOLOGY; PROTEIN BINDING; TUMOR CELL LINE;

CELL LINE, TUMOR; CELL MOVEMENT; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME ACTIVATION; GENE EXPRESSION REGULATION, NEOPLASTIC; HEPATOBLASTOMA; HUMANS; MITOGEN-ACTIVATED PROTEIN KINASE KINASES; NF-KAPPA B; PROTEIN BINDING; PROTO-ONCOGENE PROTEINS; RECEPTORS, CYTOKINE; RECEPTORS, THROMBOPOIETIN; SIGNAL TRANSDUCTION; THROMBOPOIETIN;

EID: 33644797198     PISSN: 01931857     EISSN: 15221547     Source Type: Journal    
DOI: 10.1152/ajpgi.00350.2004     Document Type: Article

References (56)

1. Abiru S, Nakao K, Ichikawa T, Migita K, Shigeno M, Sakamoto M, Ishikawa H, Hamasaki K, Nakata K, and Eguchi K. Aspirin and NS-398 inhibit hepatocyte growth factor-induced invasiveness of human hepatoma cells. Hepatology 35: 1117-1124, 2002.
2. Albini A, Iwamoto Y, Kleinman HK, Martin GR, Aaronson SA, Kozlowski JM, and McEwan RN. A rapid in vitro assay for quantitating the invasive potential of tumor cells. Cancer Res 47: 3239-3245, 1987.
3. Andrew NC and Faller DV. A rapid micropreparation technique for extraction of DNA-binding proteins from limiting numbers of mammalian cells. Nucleic Acids Res 19: 2499, 1991.
4. Bae MA and Song BJ. Critical role of c-Jun N-terminal protein kinase activation in troglitazone-induced apoptosis of human HepG2 hepatoma cells. Mol Pharmacol 63: 401-408, 2003.
5. Bartley TD, Bogenberger J, Hunt P, Li YS, Lu HS, Martin F, Chang MS, Samal B, Nichol JL, Swift S, Johnson MJ, Hsu RY, Parker VP, Suggs S, Skrine JD, Merewether LA, Clogstone C, Hsu E, Hokom MM; Hornkohl A, Choi E, Pangelinan M, Sun Y, Mar V, McNinch J, Simonet L, Jacobsen F, Xie C, Shuter J, Chute H, Basu R, Selander L, Trollinger D, Sieu L, Padilla D, Trail G, Elliot G, Isumi R, Covey T, Crouse J, Garcia A, Xu W, Del Castillo J, Biron J, Cole S, Hu MCT, Pacifici R, Ponting I, Saris C, Wen D, Yung YP, Lin H, and Bosselman RA. Identification and cloning of a megakaryocyte growth and development factor that is a ligand for the cytokine receptor Mpl. Cell 77: 1117-1124, 1994.
6. Bonacchi A, Petrai I, DeFranco RMS, Lazzeri E, Annunziato F, Efsen E, Cosmi L, Romagnani P, Milani S, Failli P, Batignani G, Liotta F, Laffi G, Pinzani M, Gentilini P, and Marra F. The chemokine CCL21 modulates lymphocyte recruitment and fibrosis in chronic hepatitis C. Gastroenterology 125: 1060-1076, 2003.
7. Bonacchi A, Romagnani P, Romanelli RG, Efsen E, Annunziato F, Lasagni L, Francalanci M, Serio M, Laffi G, Pinzani M, Gentilini P, and Marra F. Signal transduction by the chemokine receptor CXCR3. Activation of Ras/ERK, Src and PI 3-K/Akt controls cell migration and proliferation in human vascular pericytes. J Biol Chem 276: 9945-9954, 2001.
8. Borge OJ, Ramsfjell V, Veiby OP, Murphy MJ Jr, Lok S, and Jacobsen SE. Thrombopoietin, but not erythropoietin promotes viability and inhibits apoptosis of multipotent murine hematopoietic progenitor cells in vitro. Blood 88: 2859-2870, 1996.
9. Borradaile NM, de Dreu LE, and Huff MW. Inhibition of net HepG2 cell apolipoprotein B secretion by the citrus flavonoid naringenin involves activation of phosphatidylinositol 3-kinase, independent of insulin receptor substrate-1 phosphorylation. Diabetes 52: 2554-2561, 2003.
10. Bouscary D, Lecoq-Lafon C, Chretien S, Zompi S, Fichelson S, Muller O, Porteu F, Dusanter-Fourt I, Gisselbrecht S, Mayeux P, and Lacombe C. Role of Gab proteins in phosphatidylinositol 3-kinase activation by thrombopoietin (Tpo). Oncogene 20: 2197-2204, 2001.
11. Brizzi MF, Battaglia E, Montrucchio G, Dentelli P, Del Sorbo L, Garbarino G, Pegoraro L, and Camussi G. Thrombopoietin stimulates endothelial cell motility and neoangiogenesis by a platelet-activating factor-dependent mechanism. Circ Res 84: 785-796, 1999.
12. Cardier JE. Effects of megakaryocyte growth and development factor (thrombopoietin) on liver endothelial cells in vitro. Microvasc Res 58: 108-113, 1999.
13. Cardier JE and Dempsey J. Thrombopoietin and its receptor, c-mpl, are constitutively expressed by mouse liver endothelial cells: evidence of thrombopoietin as a growth factor for liver endothelial cells. Blood 91: 923-929, 1998.
14. Carloni V, Romanelli RG, Mercurio AM, Pinzani M, Laffi G, Cotrozzi G, and Gentilini P. Knockout of alpha6 beta1-integrin expression reverses the transformed phenotype of hepatocarcinoma cells. Gastroenterology 115: 433-442, 1998.
15. Chen LF and Greene WC. Shaping the nuclear action of NF-kappaB. Nat Rev Mol Cell Biol 5: 392-401, 2004.
16. Cichy SB, Uddin S, Danilkovich A, Guo S, Klippel A, and Unterman TG. Protein kinase B/Akt mediates effects of insulin on hepatic insulinlike growth factor-binding protein-1 gene expression through a conserved insulin response sequence. J Biol Chem 273: 6482-6487, 1998.
17. Columbyova L, Loda M, and Scadden DT. Thrombopoietin receptor expression in human cancer cell lines and primary tissues. Cancer Res 55: 3509-3512, 1995.
18. Cuenda A and Alessi DR. Use of kinase inhibitors to dissect signaling pathways. Methods Mol Biol 99: 161-175, 2000.
19. Drachman JG, Rojnuckarin P, and Kaushansky K. Thrombopoietin signal transduction: studies from cell lines and primary cells. Methods 17: 238-249, 1999.
20. Efsen E, Grappone C, DeFranco RM, Milani S, Romanelli RG, Bonacchi A, Caligiuri A, Failli P, Annunziato F, Pagliai G, Pinzani M, Laffi G, Gentilini P, and Marra F. Up-regulated expression of fractalkine and its receptor CX3CR1 during liver injury in humans. J Hepatol 37: 39-47, 2002.
21. Fibbe WE, Heemskerk DP, Laterveer L, Pruijt JF, Foster D, Kaushansky K, and Willemze R. Accelerated reconstitution of platelets and erythrocytes after syngeneic transplantation of bone marrow cells derived from thrombopoietin pretreated donor mice. Blood 86: 3308-3313, 1995.
22. Folman CC, Ooms M, Kuenen BB, de Jong SM, Vet RJ, de Haas M, and von dem Borne AE. The role of thrombopoietin in post-operative thrombocytosis. Br J Haematol 114: 126-133, 2001.
23. Goulis J, Chau TN, Jordan S, Mehta AB, Watkinson A, Rolles K, and Burroughs AK. Thrombopoietin concentrations are low in patients with cirrhosis and thrombocytopenia and are restored after orthotopic liver transplantation. Gut 44: 754-758, 1999.
24. Gurney AL and de Sauvage FJ. Dissection of c-Mpl and thrombopoietin function: studies of knockout mice and receptor signal transduction. Stem Cells 14: 116-123, 1996.
25. Hah N and Lee ST. An absolute role of the PKC-dependent NF-kappaB activation for induction of MMP-9 in hepatocellular carcinoma cells. Biochem Biophys Res Commun 305: 428-433, 2003.
26. Hino M, Nishizawa Y, Tagawa S, Yamane T, Morii H, and Tatsumi N. Constitutive expression of the thrombopoietin gene in a human hepatoma cell line. Biochem Biophys Res Commun 217: 475-481, 1995.
27. Jelkmann W. The role of the liver in the production of thrombopoietin compared with erythropoietin. Eur J Gastroenterol Hepatol 13: 791-801, 2001.
28. Johnson GL and Lapadat R. Mitogen-activated protein kinase pathways mediated by ERK, JNK, and p38 protein kinases. Science 298: 1911-1912, 2002.
29. Kaser A, Brandacher G, Steurer W, Kaser S, Offner FA, Zoller H, Theurl I, Widder W, Molnar C, Ludwiczek O, Atkins MB, Mier JW, and Tilg H. Interleukin-6 stimulates thrombopoiesis through thrombopoietin: role in inflammatory thrombocytosis. Blood 98: 2720-2725, 2001.
30. Kaushansky K. Thrombopoietin: the primary regulator of platelet production. Blood 86: 429-431, 1995.
31. Kaushansky K, Lin N, Grossmann A, Humes J, Sprugel KH, and Broudy VC. Thrombopoietin expands erythroid, granulocyte-macrophage, and megakaryocytic progenitor cells in normal and myelosuppressed mice. Exp Hematol 24: 265-269, 1996.
32. Kimura S, Roberts AW, Metcalf D, and Alexander WS. Hematopoietic stem cell deficiencies in mice lacking c-Mpl, the receptor for thrombopoietin. Proc Natl Acad Sci USA 95: 1195-1200, 1998.
33. Kirito K, Watanabe T, Sawada K, Endo H, Ozawa K, and Komatsu N. Thrombopoietin regulates Bcl-xL gene expression through Stat5 and phosphatidylinositol 3-kinase activation pathways. J Biol Chem 277: 8329-8337, 2002.
34. Kobayashi M, Laver JH, Kato T, Miyazaki H, and Ogawa M. Recombinant human thrombopoietin (Mpl ligand) enhances proliferation of erythroid progenitors. Blood 86: 2494-2499, 1995.
35. Komura E, Matsumura T, Kato T, Tahara T, Tsunoda Y, and Sawada T. Thrombopoietin in patients with hepatoblastoma. Stem Cells 16: 329-333, 1998.
36. Komura-Naito E, Matsumura T, Sawada T, Kato T, and Tahara T. Thrombopoietin in patients with hepatoblastoma. Blood 89: 101-107, 1997.
37. Linari S, Vannucchi AM, Ciolli S, Leoni F, Caporale R, Grossi A, Pagliai G, Santini V, Paoletti F, and Rossi Ferrini P. Coexpression of erythroid and megakaryocytic genes in acute erythroblastic (FAB M6) and megakaryoblastic (FAB M7) leukaemias. Br J Haematol 102: 1335-1337, 1998.
38. Marra F, Ghosh Choudhury G, and Abboud HE. Interferon-γ-mediated activation of STAT1α regulates growth factor-induced mitogenesis. J Clin Invest 98: 1218-1230, 1996.
39. Martin TG 3rd, Somberg KA, Meng YG, Cohen RL, Heid CA, de Sauvage FJ, and Shuman MA. Thrombopoietin levels in patients with cirrhosis before and after orthotopic liver transplantation. Ann Intern Med 127: 285-288, 1997.
40. Mitsiades CS, Mitsiades N, and Koutsilieris M. The Akt pathway: molecular targets for anti-cancer drug development. Curr Cancer Drug Targets 4: 235-256, 2004.
41. Nakanishi K, Fujimoto J, Ueki T, Kishimoto K, Hashimoto-Tamaoki T, Furuyama J, Itoh T, Sasaki Y, and Okamoto E. Hepatocyte growth factor promotes migration of human hepatocellular carcinoma via phosphatidylinositol 3-kinase. Clin Exp Metastasis 17: 507-514, 1999.
42. Peck-Radosavljevic M, Wichlas M, Pidlich J, Sims P, Meng G, Zacherl J, Garg S, Datz C, Gangl A, and Ferenci P. Blunted thrombopoietin response to interferon alfa-induced thrombocytopenia during treatment for hepatitis C. Hepatology 28: 1424-1429, 1998.
43. Parola M, Robino G, Marra F, Pinzani M, Bellomo G, Leonarduzzi G, Chiarugi P, Camandola S, Poli G, Waeg G, Gentilini P, and Dianzani MU. HNE interacts directly with JNK isoforms in human hepatic stellate cells. J Clin Invest 102: 1942-1950, 1998.
44. Rojnuckarin P, Drachman JG, and Kaushansky K. Thrombopoietin-induced activation of the mitogen-activated protein kinase (MAPK) pathway in normal megakaryocytes: role in endomitosis. Blood 94: 1273-1282, 1999.
45. Santini V, Scappini B, Grossi A, Gozzini A, Bonsi L, Pagliai G, Rossi Ferrini P, and Bagnara GP. Lyn kinase is activated following thrombopoietin stimulation of the megakaryocytic cell line B1647. Haematologica 87: 1242-1247, 2002.
46. Spector M, Nguyen VA, Sheng X, He L, Woodward J, Fan S, Baumgarten CM, Kunos G, Dent P, and Gao B. Activation of mitogen-activated protein kinases is required for alpha1-adrenergic agonist-induced cell scattering in transfected HepG2 cells. Exp Cell Res 258: 109-120, 2000.
47. Strain AJ, Crosby HA, Nijjar S, Kelly DA, and Hubscher SG. Human liver-derived stem cells. Semin Liver Dis 23: 373-384, 2003.
48. Sungaran R, Markovic B, and Chong BH. Localization and regulation of thrombopoietin mRNA expression in human kidney, liver, bone marrow, and spleen using in situ hybridization. Blood 90: 2849-2850, 1997.
49. Suzuki A, Hayashida M, Kawano H, Sugimoto K, Nakano T, and Shiraki K. Hepatocyte growth factor promotes cell survival from fas-mediated cell death in hepatocellular carcinoma cells via Akt activation and Fas-death-inducing signaling complex suppression. Hepatology 32: 796-802, 2000.
50. Szczesna-Skorupa E, Chen CD, Liu H, and Kemper B. Gene expression changes associated with the endoplasmic reticulum stress response induced by microsomal cytochrome p450 overproduction. J Biol Chem 279: 13953-13961, 2004.
51. Tai DI, Tsai SL, Chang YH, Huang SN, Chen TC, Chang KS, and Liaw YF. Constitutive activation of nuclear factor kappaB in hepatocellular carcinoma. Cancer 89: 2274-2281, 2000.
52. Vigon I, Mornon JP, Cocault L, Mitjavila MT, Tambourin P, Gisselbrecht S, and Souyri M. Molecular cloning and characterization of MPL, the human homolog of the v-mpl oncogene: identification of a member of the hematopoietic growth factor receptor superfamily. Proc Natl Acad Sci USA 89: 5640-5644, 1992.
53. Wendling F. Thrombopoietin: its role from early hematopoiesis to platelet production. Haematologica 84: 158-166, 1999.
54. Wolber EM, Ganschow R, Burdelski M, and Jelkmann W. Hepatic thrombopoietin mRNA levels in acute and chronic liver failure of childhood. Hepatology 29: 1739-1742, 1999.
55. Wolber EM and Jelkmann W. Interleukin-6 increases thrombopoietin production in human hepatoma cells HepG2 and Hep3B. J Interferon Cytokine Res 20: 499-506, 2000.
56. - primitive progenitor cells. Blood 88: 1619-1631, 1996.